GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
New Treatments for Alzheimer’s Disease
The global market value of Alzheimer’s disease (AD) therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease. More than 150 companies are working on new treatments for AD, including approximately 15 multinationals and 30 generics companies. Which new therapies do you think will be most successful at treating AD?